Zobrazeno 1 - 10
of 68
pro vyhledávání: '"heart atrium fibrillation"'
Autor:
J. Stevanovic, Maarten J. Postma, Mark H. Rozenbaum, Hoa H. Le, Robert G. Tieleman, M. Pompen
Publikováno v:
PLoS ONE, 9(8):e103974. PUBLIC LIBRARY SCIENCE
PLoS ONE, Vol 9, Iss 8, p e103974 (2014)
PLoS ONE
PLoS ONE, Vol 9, Iss 8, p e103974 (2014)
PLoS ONE
BackgroundStroke prevention is the main goal of treating patients with atrial fibrillation (AF). Vitamin-K antagonists (VKAs) present an effective treatment in stroke prevention, however, the risk of bleeding and the requirement for regular coagulati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4db542644096114491c313abb96ca58f
https://doi.org/10.1371/journal.pone.0103974
https://doi.org/10.1371/journal.pone.0103974
Publikováno v:
Journal of Surgical Research. 178:92-95
Background: Subclinical atrial stunning (AS) (left atrial dysfunction) may increase vulnerability to oxidative and inflammatory stressors, thus increasing the likelihood of postoperative supraventricular arrhythmias, especially atrial fibrillation (A
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d39f07504cf1662f7018bdfb95cb638d
https://doi.org/10.1016/j.jss.2012.01.051
https://doi.org/10.1016/j.jss.2012.01.051
Publikováno v:
Journal of Thrombosis and Haemostasis. 9:265-274
Venous thromboembolism (VTE) is most commonly initially treated with low molecular weight heparin (LMWH), fondaparinux, or unfractionated heparin, in combination with vitamin-K antagonists (VKA) for long-term treatment. VKA have some drawbacks, howev
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dris___00893::47dc3bcf0ddcacc532e4abdc0d741fa2
https://hdl.handle.net/11370/d371a8da-8759-4a76-8c88-4463a3a104e2
https://hdl.handle.net/11370/d371a8da-8759-4a76-8c88-4463a3a104e2
Publikováno v:
Netherlands Journal of Medicine. 69(6):268-273
Anticoagulants are effective agents in reducing the risk of thromboembolism but the most important adverse effect of these agents is the occurrence of bleeding. Bleeding complications may occur spontaneously but the risk of bleeding is particularly i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dris___00893::6e7684374c9fae9dff7e0215be10367d
https://hdl.handle.net/11370/cae6c57e-7aff-45f8-8c5b-052f4158c9c6
https://hdl.handle.net/11370/cae6c57e-7aff-45f8-8c5b-052f4158c9c6
Publikováno v:
Netherlands Journal of Medicine. 68(2):68-76
The most important adverse effect of antithrombotic treatment is the occurrence of bleeding. in case of serious or even life-threatening bleeding in a patient who uses anticoagulant agents or when patient on anticoagulants needs to undergo an urgent
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dris___00893::1acb4674a5981774c3e3323b75e55b7a
http://www.njmonline.nl/getpdf.php?id=888
http://www.njmonline.nl/getpdf.php?id=888
Publikováno v:
Nederlands Tijdschrift voor Geneeskunde. 153(33):1622-1628
If patients being treated with anticoagulants need to undergo an operation then physicians need to consider whether to suspend the use of this medication or to allow its use to be continued. Suspending the use of anticoagulants increases the risk of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dris___01423::f9ae8e6e41d11b3940a2af2c7a1c9082
https://research.rug.nl/en/publications/708fb08b-cb28-44a7-9fca-97c8f140c3a3
https://research.rug.nl/en/publications/708fb08b-cb28-44a7-9fca-97c8f140c3a3
Autor:
Asuman Kaftan, Doğu İsmail Kılıç, Ali Vefa Özcan, Harun Evrengul, Halil Tanriverdi, Omer Caglıyan
Publikováno v:
International Journal of Cardiology. 135:e30-e33
Myocardial injury may complicate allergic reactions caused by several medications. We evaluated a case of a myocardial injury with transient ST segment elevation in a 72 year-old man presenting with collapse caused by sulbactam-ampicilllin assumption
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4feb6d2bd6fbf4d9cb6b688890f32628
https://doi.org/10.1016/j.ijcard.2008.03.069
https://doi.org/10.1016/j.ijcard.2008.03.069
Publikováno v:
Seminars in thrombosis and hemostasis. 35(6):560-567
Most patients with atrial fibrillation need anticoagulant treatment with vitamin K antagonists for prevention of thromboembolism, in particular ischemic stroke. Many studies show the efficacy of this treatment but also that it is difficult to keep pa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dris___01423::78f0acdfba46f8302a6b2e49c03046a3
https://doi.org/10.1055/s-0029-1240016
https://doi.org/10.1055/s-0029-1240016
Autor:
Basri Amasyali, Ayhan Kilic, Sedat Kose, Halil Tanriverdi, Hasan Turhan, Harun Evrengul, Turgay Celik
Publikováno v:
Ann Noninvasive Electrocardiol
Annals of Noninvasive Electrocardiology, Vol 11, Iss 2, Pp 154-162 (2006)
Annals of Noninvasive Electrocardiology, Vol 11, Iss 2, Pp 154-162 (2006)
Background: Reduced heart rate recovery (HRR) in coronary artery disease (CAD) is predictive of increased cardiovascular mortality and is related to reduced parasympathetic tonus. Objective: To investigate HRR and heart rate variability (HRV) measure
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::720ce8e3888571061b8388c6c3cb5e15
https://doi.org/10.1111/j.1542-474x.2006.00097.x
https://doi.org/10.1111/j.1542-474x.2006.00097.x
Publikováno v:
Blood. 124(21)
Background: It is well known that atrial fibrillation (AF) induces a hypercoagulable state, which significantly increases stroke risk in patients with AF contributing to morbidity and mortality in these patients. Active coagulation factors can also p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dris___00893::237efcd5331b9875b9d234cad3c0fb57
https://hdl.handle.net/11370/2a98929a-5f37-485b-8eae-bb768f39f262
https://hdl.handle.net/11370/2a98929a-5f37-485b-8eae-bb768f39f262